Michael Rynerson

A New CEO for ACTEON

Michael Rynerson is appointed Chief Executive Officer of ACTEON, effective June 1st, 2020

Read our press release
Read our press release

X-MIND PRIME

X-MIND PRIME

EFFICIENT 2D & 3D DIAGNOSIS

Learn More
Learn More
Piezotome Cube

Piezotome Cube

Less Trauma, Less Drama

Learn More
Learn More
X-Mind TRIUM

X-MIND TRIUM

3D TECHNOLOGY WITH INSTANT VOLUME MEASUREMENT AND BONE DENSITY ASSESSMENT

Learn More
Learn More
Newtron

NEWTRON

MAKE THE SWITCH TODAY

Learn More
Learn More
SOPIX 2

SOPIX 2

A PERFECT IMAGE EVERY TIME

Learn More
Learn More
Expasyl Exact - Effective Gingival Retraction

EXPASYL Exact

Effective Gingival Retraction

Learn More
Learn More